WHO manages batch of Pfizer and Moderna vaccines for poor countries

December 15, 2020

The World Health Organization (WHO), established a mechanism to rapidly distribute vaccines against Covid-19 to poor countries, in this context it announced that it is already in dialogue with Pfizer and Moderna.

The Covax mechanism, (Global Access to Vaccines against covid-19) is an international device created by the WHO with the Alliance for Vaccines (Gavi) to accelerate fair access to the tools to fight the disease.

WHO aims to supply some 2 billion doses to poor countries by the end of 2021 and has so far secured a few hundred million doses of the vaccines developed by AstraZeneca, Novavax and Sanofi-GSK, but which have not yet been authorized.

“We are also in talks with Pfizer and Moderna to find out if these products can be part of the initial phase of launching vaccines,” said the chief adviser to the head of the WHO, Bruce Aylward.

However, “we must also make sure they are priced appropriately for the populations and countries we are trying to help,” he said.

Pfizer boss Albert Bourla publicly pledged to reduce the price of the vaccine in low-income countries.

The WHO indicated that the Covax mechanism wishes to evaluate “any product that has demonstrated its efficacy, safety and quality”, including vaccines developed by China and Russia “if they meet the standards of efficacy and safety.”

With the arrival of vaccines “there is light at the end of the tunnel”, although this is “long” pointed out the head of the agency.

Agregue un comentario

Su dirección de correo no se hará público. Los campos requeridos están marcados *